Status:
COMPLETED
Multi-drug Resistant Gram-negative Bacteria and Veno-venous Extracorporeal Membrane Oxygenation (ECMO)
Lead Sponsor:
University of Padova
Collaborating Sponsors:
Azienda Ospedaliera Mater Domini di Catanzaro
Policlinico di Bari Giovanni XXIII
Conditions:
Respiratory Distress Syndrome, Adult
Multi-antibiotic Resistance
Eligibility:
All Genders
18+ years
Brief Summary
Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is a life-support technique used in patients with most severe acute respiratory distress syndrome (ARDS). ARDS is a life-threatening form of r...
Detailed Description
Noteworthy, the most frequent NIs occurring during VV-ECMO are pneumonia (\>40%) and, secondly, blood-stream infections (3-18%). The situation is more challenging for Gram-negative bacilli: more than ...
Eligibility Criteria
Inclusion
- ARDS
- VV-ECMO
Exclusion
- pregnancy
- age \< 18
- uncompleted records
- survival \< 24h after ECMO connection
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
279 Patients enrolled
Trial Details
Trial ID
NCT06199141
Start Date
January 1 2017
End Date
December 31 2023
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Università Padova
Padua, Italy, 35126